CAPSTONE HOLDING CORP.

Highlights Capstone Holding Corp.

Equities

CAPS

US14068E2081

Market Closed - OTC Markets Other stock markets 03:15:21 2024-06-04 pm EDT			5-day change	1st Jan Change
4.1 ^USD	-.--%		-.--%	-21.15%

Apr. 01	Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Capstone Holding Corp. Announces Change in Board of Directors	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 31	CI
Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Capstone Therapeutics Corp. acquired an unknown stake Instone Co.	20-03-31	CI
Capstone Therapeutics Corp. entered into an agreement to acquire an unknown stake in Instone Co.	20-03-26	CI
Capstone Therapeutics Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-13	CI
Capstone Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-13	CI
Capstone Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-22	CI
Capstone Therapeutics Corp. and LipimetiX Development, Inc. Announce Patent Application for Novel, More Potent Chimeric Apo E Mimetic Peptides	15-07-23	CI
Capstone Therapeutics and LipimetiX Development Announce Phase 1b/2a Study Results for AEM-28 Showing Safety and Biomarker Efficacy Signals	14-12-16	CI
Capstone Therapeutics Corp. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014	14-11-13	CI
Capstone Therapeutics and LipimetiX Development, LLC Announce Phase 1A Results for AEM-28	14-09-02	CI
Capstone Therapeutics Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014	14-08-14	CI
Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1b/2a Human Clinical Trial in Refractory Hypercholesterolemic Subjects	14-06-11	CI
Capstone Therapeutics and LipimetiX Development, LLC Announces Initiation of Dosing for AEM-28 Phase 1 Human Clinical Trial in LDL/Non-HDL Cholesterol Reduction	14-04-08	CI
Capstone Therapeutics Announces Consolidated Earnings Results for the Year Ended December 31, 2013	14-03-27	CI
Capstone Therapeutics Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2013	13-08-14	CI
Capstone Therapeutics Corp. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2013	13-05-15	CI
Capstone Therapeutics Corp. and Lipimetix LLC Enters into a Joint Venture	12-08-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer